Company · CIK 2079272
Lakewood-Amedex Biotherapeutics Inc.
| CIK | 2079272 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | NV |
| Business address | FL |
| Listed | LABT (Nasdaq) |
| First annual or quarterly report | 2026-05-22 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-299027 | 2026-09-18 | 2026-09-24 | 2 | |
| 333-295497 | 2026-05-01 | 2026-05-14 | 3 | |
| 333-292664 | 2026-01-09 | 2026-04-23 | 8 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-24 | EFFECTDeclared effective | 333-299027 | 9999999995-26-003056 |
| 2026-09-18 | S-1Registration filed | 333-299027 | 0001213900-26-101512 |
| 2026-08-24 | DRSDraft made public | 377-09702 | 0001213900-26-092773 |
| 2026-05-14 | 424B4Final prospectus | 333-295497 | 0001213900-26-056648 |
| 2026-05-13 | EFFECTDeclared effective | 333-295497 | 9999999995-26-001622 |
| 2026-05-01 | S-1Registration filed | 333-295497 | 0001213900-26-050936 |
| 2026-04-23 | 424B4Final prospectus | 333-292664 | 0001213900-26-047113 |
| 2026-04-17 | EFFECTDeclared effective | 333-292664 | 9999999995-26-001238 |
| 2026-04-06 | S-1/AAmendment | 333-292664 | 0001213900-26-040254 |
| 2026-04-01 | S-1/AAmendment | 333-292664 | 0001213900-26-037938 |
| 2026-03-11 | S-1/AAmendment | 333-292664 | 0001213900-26-026195 |
| 2026-02-13 | S-1/AAmendment | 333-292664 | 0001213900-26-015814 |
| 2026-02-05 | S-1/AAmendment | 333-292664 | 0001213900-26-012492 |
| 2026-01-09 | S-1Registration filed | 333-292664 | 0001213900-26-003037 |
| 2025-07-31 | DRSDraft made public | 377-08278 | 0001213900-25-070092 |